Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-014400

Chief Commercial Officer gave up 16,450 shares (to pay taxes)

  • Chief Commercial Officer acquired 39,996 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirby Daniel Gordon Chief Commercial Officer 2026-02-10 Option exercise +39,996 69,996 D: show line 1 in the form
Kirby Daniel Gordon Chief Commercial Officer 2026-02-10 Shares withheld for taxes −16,450 $2.60 $42,770 53,546 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirby Daniel Gordon Chief Commercial Officer 2026-02-10 Option exercise · Restricted Stock Units −39,996 80,004 D: show line 3 in the form
Loading xslF345X05/tm266006-1_4seq1.xml…